Blastic plasmacytoid dendritic cell neoplasm transformed from essential thrombocythemia with leukemic picture and no skin involvement – A case study
PDF

Keywords

Haematology
Cancer
Blastic plasmacytoid dendritic cell neoplasm

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare and fatal condition, which usually affects elderly males. It presents in the skin with frequent involvement of the bone-marrow, peripheral blood and lymph nodes. It has a dismal prognosis, with most patients dying within one year. The diagnosis is frequently challenging, with a characteristic immunophenotype. The best modality of treatment remains to be defined. Generally, patients require acute leukaemialike induction chemotherapy regimen. Here we present a local case who transformed from essential thrombocythemia into BPDCN over a 20-year period with sudden leukemic picture, and interestingly without any typical skin lesions.

https://doi.org/10.48037/mbmj.v9i1.1359
PDF

References

Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016;174(2):188-202. Available from: https://doi.org/10.1111/bjh.14146

Sapienza MR, Pileri A, Derenzini E, et al. Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects. Cancers. 2019;11(5):595. Available from: https://doi.org/10.3390/cancers11050595

Swerdlow S, Campo E, Harris NL, et al. Eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2017.

Facchetti F. Plasmacytoid dendritic cell neoplasms. In: Orazi A, Weiss LM, Foucar KA, Knowles DM, eds. Knowles neoplastic hematopathology. 3rd ed. Philadelphia PA: Lippincott Williams & Wilkins, 2013.

Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4+ CD56+ malignancies. Blood. 2002;99(5):1556-63. Available from: https://doi.org/10.1182/blood.v99.5.1556

Garnache-Ottou F, Vidal C, Biichlé S, et al. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv. 2019;3(24):4238-51. Available from: https://doi.org/10.1182/bloodadvances.2019000647

Julia F, Petrella T, Beylot-Barry M, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013;169(3):579-86. Available from: https://doi.org/10.1111/bjd.12412

Pagano L, Valentini CG, Pulsoni A, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013;98(2):239. Available from: https://doi.org/10.3324/haematol.2012.072645

Rauh MJ, Rahman F, Good D, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement:case series and literature review. Leuk Res. 2012;36(1):81-6. Available from: https://doi.org/10.1016/j.leukres.2011.07.033

Wang H, Cao J, Hong X. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta haematol. 2012;127(2):124-7. Available from: https://doi.org/10.1159/000334703